Organotherapie in der Onkologie

Author(s): Michels-Giermanns, R., Scheeren, T., Walter, F.

Journal/Book: Erfahrungsheilkunde. 1989; 38/8: 467-472.

Abstract: The biogenously efficacious substances in organotherapeutic agents used for in vitro experiments lead an all animal and human tumour cell lines tested so far to a dosedependant inhibited proliferation which even leads to pyknosis. Using foetal/ juvenile tissue in animal experiments in case of autochthonous, chemically induced tumours and transplantation tumours a longer survival time, less tumour operations, smaller tumour size as well as a modified growth of tumour can be observed. After having been in contact with foetal tissue, surviving tumour cells partially loose their malignancy, partially they (re-) differentiate. Some uncontradicted studies in human medicine prove a longer survival time, however, a considerably improved quality of life due to chemotherapy with foetal xenogenetic tissue.

Zurück | Weiter